Quarterly results for the quarter ended 30.06.2026

‘%VINEET LABORA' LMITED Vineet Laboratories Limited Regd.Office: SY. No. 11/A3, Saheb Nagar, Kurdu Vill, Chintal Kunta, Eshwaramma Nilayam, L B Nagar Hyderabad. CIN- L24304TG2016PLC112888 Phone: 040-24128833; Email Id: cs@vineetlabs.co.in; Website: vineetlabs.co.in To Date: 26.10.2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Fort, Bandra Kurla Complex, Mumbai 400 001. Bandra (E) BSE Scrip Code: 543298 Mumbai — 400 051 NSE Scrip Code: VINEETLAB Dear Sir/Madam, Sub: Outcome of board meeting under regulation 30 of SEBI (Listing Obligations and Disclosure requirements) regulations, 2015 Unit: Vineet Laboratories Limited With reference to the subject cited, this is to inform the Exchange that at the Board meeting of M/s. Vineet Laboratories Limited held on Monday, the 26" day of October, 2026 at 5.30 P.M. at the registered office of the Company the following were duly considered and approved by the Board: 1. Un audited financial results for the quarter ended 30.06.2026 (Attached) 2. Limited Review Report for the quarter ended 30.06.2026 (Attached). The meeting of the Board of Directors commenced at 5.30 P.M (IST) and concluded at 06.25 P.M (IST) This is for the information and records of the Exchange, please. Thanking you. Yours faithfully For Vineet Laboratories limited Kathulla Rajesh Kumar Whole Time Director (DIN: 05349717) VINEET LABORATORIES LIMITED CIN:L24304TG2016PLC112888. SY. No. 11/A3, Saheb nagar, Kurdu Vill, Chintal Kunta, Eshwaramma Nilayam, L B Nagar, Hyderabad, Telangana-500074, India. (All amounts are INR Lakh except share data or unless otherwi stated)= Statement of Audited Financial Results for the Quarter ended june 30,2026 Quarterended | Quarterended | Quarterended | Yearended . June 30,202 | March31,2026 | June 30205 | March 312026 SNo Particulars. (Unaudited) (Audited) (Unaudited) (Audited) 0 income from operations 2) Net Salestincome from operations 1039| 1.889.14 74418 5940.10 Total income from operations 103932 1,889.14 74418 594010 I Other income 10.80 298 1.81 10.39 " Total Income (1 1) 1,050.12 189212 745.99 595049 Vi [Expenses ) Cosotf materials Consumed 1000.13 230681 120092 618834 b) Changes i inventories of finished goods, workin progress and siockin- tradeincrease)idecrease (386.64) (1,066.91) (139.72) (@.32753) ) Employes benefits expenses 13381 12032 1059 40963 ) Finance cost 9693 9914 6122 48852 ) Depreciation and amoriisation expenses 6037] 5387 6254 24149 ) Other expenses 6695 271943 14523 8177 Total expenses 97156 1,79266 836.15 5822.22 v Profit(loss) before exceptional items and tax (Il - V) 856 9946 (90.16) 12827 VI [Exceptonalitmes ¥ & Vi [Profit(loss) before Tax (v VI) 856 9946 (90.16) 12827 Vil [Taxexpense: a Gurrent tax (nef) - b. Deferred tax(net) (7286) 2694 (3.55) 1718 Total tax expense (7286) 2694 (3.59) 1748 X |Profit(loss) for the period (VILVII) 15143 7251 @6.61) 11108 x (Other comprehensive income(OCI) 2) (i) tems that will not be reclassified to profit or loss: - 6591 . 6591 (i) Income tax relating to ems that will not be: reclassified to profit orloss - (1659) 5 (1659) b) 1) ftems that will be reclassified o profi or loss = . 5 - (i) Income tax elating to items that will be reclassified o proftor loss - . - - Total other comprehensive incomel(loss) - 4932 - 932 Xi [Total comprehensive incomel(loss) net of tax for the Periodiyear (X+X)) 151.43 12183 @6.61) 16040 X1 |Paid Up Equity Share Capital (Face Value of Rs.101- each) 192063 192063 921.90 192063 Xl |Other equity 263957 Earnings per equity share (of Rs. 10/- each) xv (not annualised for the quarters) (i) Basic or3 043 (0.94) 100) (i) Diluted 073 043 ©0.94) 100) Notes ) The above statement of audited finandil resuls of Vineet Laboratories Limited (the Company’), which have been prepared in accordance with the Indian Accounting Standards (Ind AS") prescribed under Section 133 of the Companies Adt, 2013 (‘the Act) read with relevant rufes issued thereunder, other accounting principles generally accepted i Inia and guidelnes issued by the Securities and Exchange Board of India (‘SEBI') viere reviewed and recommended by the Audit Commitee and approved by the Board of Drectors at their meetings heid on Oct 26, 2026. The Statutory Auditors have issued an unqualified report thereon. b) The company operates in one reportable business segment .. Active pharmaceuticals ingredient and intermediates. Hence segmental reporting as per Ind AS 108 is not applicable ) The rests for the Quarter ended 30 june, 20ar2e a6lso available on websoif tBSeE Limited, NSE Linited and on the Company's websile. ) Figures for the previous periods have been rearranged) reclassiied wherever necessary to Confom 1o the current period presentation. &) The figures for the quarter ended 31 march, 2026 are the balancing figures between the audited figures oft he ful financial year and limited reviewed year to date figures upto the third quarter of the financial year. ) On November 21, 2025, the Governmert of India has consolidated 29 existing labour legislations into unfed framework comprising four Labour codes viz Code on wages 2019, Code on Social ‘Security 2020, Industrial Relation Code 2020 and Occupational Satety, Health and Working Condition Code 2020 (collctively referred to as the New Labour Codes) The Ministy of Labour & Employment pubished draft Central Rules and FAQs to enable assessment o the financial impact due to changes in reguiations. The Company is already in compliance with the basic wages citeria s prescribed under New Labour Codes for own employeaensd there s no material impact on the company. For and on behalf of Board of Directors. Vineet Laboratories Limited Date 26102026 Place: Hyderabad. Kathuila Rajesh Kumar Whole Time Director DIN: 05349717 NSVR & ASSOCIATES ur, CHARTERED ACCOUNTANTS INDIA Independent Auditor’s Review Report on the Quarter ended 30™ June, 2026 Unaudited Financial Results of the Company pursuant to the Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To The Board of Directors of VINEET LABORATORIES LIMITED I. We have reviewed the accompanying statement of unaudited financial results of VINEET LABORATORIES LIMITED (‘the Company') for the quarter ended 30“June,2026 attached herewith, being submitted by the Company pursuant (o the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations’) 2. This Statement, which is the responsibility of the Company's Management and has been approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder (Ind AS 34') and other recognised accounting principies generally accepted in India and is in compliance with the Regulations. Our responsibility is lo express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standards on Review Engagement (SRE) 2410 ‘Review of Interim Financial Information Performed by the Independent Auditor of the entity” issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial results are free from malcrial misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly we do not express an audit opinion. 4. Based on our review conducted as stated above, nothing has come (o our attention that causes us to believe that the accompanying statement, prepared in accordan [Showing first 8,000 characters — download PDF for full document]